Bergamot rehabilitation AgaINst agitation in dementia (BRAINAID): Study protocol for a randomized, double‐blind, placebo‐controlled trial to assess the efficacy of furocoumarin‐free bergamot loaded in a nanotechnology‐based delivery system of the essential oil in the treatment of agitation in elderly affected by severe dementia

Pain is underdiagnosed and often not adequately treated, contributing to behavioral and psychological symptoms of dementia (BPSD). BPSD are treated with atypical antipsychotics that are associated with severe cerebrocardiovascular effects. Interestingly, treatment of pain may reduce agitation. Resea...

Descripción completa

Detalles Bibliográficos
Autores principales: Scuteri, Damiana, Sandrini, Giorgio, Tamburin, Stefano, Corasaniti, Maria Tiziana, Nicotera, Pierluigi, Tonin, Paolo, Bagetta, Giacinto
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd. 2021
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290822/
https://www.ncbi.nlm.nih.gov/pubmed/34435395
http://dx.doi.org/10.1002/ptr.7223

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9290822/
https://www.ncbi.nlm.nih.gov/pubmed/34435395
http://dx.doi.org/10.1002/ptr.7223

Ejemplares similares